Favipiravir for treating patients with novel coronavirus (COVID-19): protocol for a systematic review and meta-analysis of randomised clinical trials

INTRODUCTION: An outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was reported in Wuhan, China, in mid-December 2019, and declared a pandemic by the WHO on 11 March 2020. Due to the unknown nature of the disease and the lack of specific drugs, several potential treatments wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Arab-Zozani, Morteza, Hassanipour, Soheil, Ghoddoosi-Nejad, Djavad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397976/
https://www.ncbi.nlm.nih.gov/pubmed/32737100
http://dx.doi.org/10.1136/bmjopen-2020-039730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397976/
https://www.ncbi.nlm.nih.gov/pubmed/32737100
http://dx.doi.org/10.1136/bmjopen-2020-039730

Ejemplares similares